Výsledky vyhledávání

Efectividad de la gabapentina en el tratamiento de la espasticidad: estudio aleatorizado, a doble ciego y controlado con placebo

Autor: J.M. Sol, Alessandro Formica, Katia Verger, Claudia Morralla

Publikováno v: Medicina Clínica. 124:81-85

Fundamento y objetivo Demostrar la eficacia y seguridad de la gabapentina en el tratamiento de la espasticidad asociada al sindrome de motoneurona superior. Pacientes y metodo En este ensayo de doble ciego piloto, de 10 semanas de duracion, se aleato

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a5c987718ed1d3b428aa17a7acc510aa
https://doi.org/10.1157/13070862

Zobrazit plný text záznamu

Decreased circulating Fas ligand in patients with familial combined hyperlipidemia or carotid atherosclerosis

Autor: Luis Miguel Blanco-Colio, C. Diaz, Gonzalo Hernández, José Luis Martín-Ventura, Jesús Egido, J.M. Sol

Publikováno v: Journal of the American College of Cardiology. 43(7):1188-1194

Objectives We sought to study whether patients with familial combined hyperlipidemia (FCH) or carotid atherosclerosis have modified circulating solubilized Fas ligand (sFasL) levels, as well as the potential modifications by atorvastatin. We also exa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a70e8acf3e9184efb6270426e5ecf0ad

Zobrazit plný text záznamu

Allelic polymorphism −491A/T in apo E gene modulates the lipid-lowering response in combined hyperlipidemia treatment

Autor: Gonzalo Hernández, X. Masramon, Miguel Pocovi, R. Aristegui, A. L. García-Otín, J.M. Sol, Fernando Civeira, C. Diaz, D. Recalde

Publikováno v: European Journal of Clinical Investigation. 32:421-428

Background Combined hyperlipidemia (CHL) is one of the dyslipidemias more frequently found in clinical practice, and lipid-lowering drugs are often necessary in its management. Some genetic loci have been associated with CHL expression, and some stud

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::952cfeeb2aad53ca5e606bef5507b4f5
https://doi.org/10.1046/j.1365-2362.2002.00996.x

Zobrazit plný text záznamu

Eficacia y seguridad de la atorvastatina en la práctica médica habitual en España (estudio Zar)

Autor: J.M. Sol, R. Aristegui, C. Diaz, José Chaves, X. Masramon, Gonzalo Hernández

Publikováno v: Clínica e Investigación en Arteriosclerosis. 13:19-25

Fundamento La hipercolesterolemia desempena un importante papel en el desarrollo de la enfermedad cardiovascular. El beneficio de un estricto control lipidico ha sido puesto en evidencia con toda claridad tanto en estudios de prevencion primaria como

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5118d3b017a791509f8dfde40e7b3f5d
https://doi.org/10.1016/s0214-9168(01)78755-4

Zobrazit plný text záznamu

Randomized crossover study of gemfibrozil versus lovastatin in familial combined hyperlipidemia: Additive effects of combination treatment on lipid regulation

Autor: Emilio Ros, J.M. Sol, Manual Vázquez, Gonzalo Hernández, Camino Rodríguez-Villar, Juan C. Laguna, Daniel Zambón, C Sanllehy, Elena Casals

Publikováno v: Metabolism. 48:47-54

The most appropriate therapy for combined hyperlipidemia remains to be determined. We compared the lipid-regulating effects of gemfibrozil and lovastatin in 30 patients with familial combined hyperlipidemia (FCHL) in a randomized, double-blind, place

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8db82e909d47ce77aa9f64d3ccc7646
https://doi.org/10.1016/s0026-0495(99)90009-4

Zobrazit plný text záznamu

Clinical Validity and Utility of the Interview for Deterioration of Daily Living in Dementia for Spanish-Speaking Communities

Autor: J.M. Sol, Miquel Aguilar, Jordi Peña-Casanova, Rafael Blesa, Peter Böhm, Gonzalo Hernández

Publikováno v: International Psychogeriatrics. 10:261-270

The assessment of activities of daily living is a central procedure in the diagnosis of dementia. Few instruments in the field allow for early detection of functional decline because the items they use refer mainly to basic activities of daily living

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::53a7622110afe57d3928422b49ac200a
https://doi.org/10.1017/s1041610298005377

Zobrazit plný text záznamu

Efficacy and Safety of Quinapril 40mg Once Daily as Monotherapy for Patients with Poorly Controlled Hypertension : The EUREKA Study

Autor: Carol Pueyo, G. Hernández, J.M. Sol, C. Diaz, Xavier Masramon

Publikováno v: Clinical drug investigation. 20(2)

Objective: We assessed the efficacy and safety of quinapril 40mg once daily for treating essential hypertension in patients with poorly controlled hypertension who were using other angiotensin-converting enzyme (ACE) inhibitors, or in those who neede

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73f015776d8cde4821e8b4440230a21f
https://pubmed.ncbi.nlm.nih.gov/23315349

Zobrazit plný text záznamu

Effect of atorvastatin and bezafibrate on plasma levels of C-reactive protein in combined (mixed) hyperlipidemia

Autor: José Chaves, Gonzalo Hernández, Fernando Civeira, J.M. Sol, P. Marques da Silva, Josefina Oliván, Juan A Gómez-Gerique, Miquel Vilardell, R. Aristegui, José Puzo, Emilio Ros, Daniel Zambón, José María Mostaza, Cristina Díaz, Xavier Pintó, J. Lima, Atomix investigators, A. Rodriguez-Botaro, Alicia Hernández

Publikováno v: Clínica e Investigación en Arteriosclerosis. 15:171-173

C-reactive protein (CRP) is a non-specific but sensitive marker of underlying systemic inflammation. High CRP plasma levels correlate with risk for future cardiovascular events. The present study evaluated the effects of atorvastatin (10–40 mg) and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d65dc9db2206cf0b1d7c1bea5219add3
https://doi.org/10.1016/s0214-9168(03)78928-1

Zobrazit plný text záznamu

Spanish multicenter normative studies (Neuronorma project): norms for the abbreviated Barcelona Test

Autor: Pablo Duque, Alfredo Robles, Gonzalo Sánchez, Maitena Lasa, Rafael Carles, Elena Alayrach, Gemma C. Monté, María Dolores Aguilar, Gracia Cucurella, Anna Salvà, Beatriz Gómez-Ansón, José Luis Molinuevo, Judit Jiménez, Carlos Martínez-Parra, Stephanie Lonsdale, Laura Casas, R.M. Manero, Jordi Peña-Casanova, Anna Frank-García, Silvia Ramos, Clara Villanueva, Sonia González, Jose Manuel Gata, Aitor Sainz, Martirio Antequera, Eva Ruiz, Yolanda Buriel, Manuel Fernández, Romina Ribas, Verónica Alfonso, Laura Jiménez, Miguel Aguilar, Mónica Serradell, Irune Quevedo, Loli Cabello, María Sagrario Barquero, Rafael Blesa, Nina Gramunt, Claudia Caprile, Carmen Antúnez, Dolores Rodríguez, Azucena Sanz, Laura Torner, Dolors Badenes, F. Hernández, Carme Pla, Maria Payno, Klaus Langohr, Noemí Cerulla, Gonzalo Sánchez-Benavides, Sonia Quiñones, J.M. Sol, Ana Molano, M. Quintana, Rafael Oliva, Peter Böhm

Publikováno v: ARCHIVES OF CLINICAL NEUROPSYCHOLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
UPCommons. Portal del coneixement obert de la UPC
Universitat Politècnica de Catalunya (UPC)
Recercat. Dipósit de la Recerca de Catalunya

The abbreviated Barcelona Test (a-BT) is an instrument widely used in Spain and Latin American countries for general neuropsychological assessment. The purpose of the present study was to provide new norms for the a-BT as part of the Neuronorma proje

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cac60b8059de9652e8eacf7ef015bd3d
https://pubmed.ncbi.nlm.nih.gov/21149392

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání